Cb Scientific Stock Current Asset
| CBSC Stock | USD 0.04 0 5.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess CB Scientific's long-term financial health and intrinsic value.
CBSC |
CB Scientific Company Current Asset Analysis
CB Scientific's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, CB Scientific has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The current asset for all United States stocks is 100.0% higher than that of the company.
CBSC Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CB Scientific's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CB Scientific could also be used in its relative valuation, which is a method of valuing CB Scientific by comparing valuation metrics of similar companies.CB Scientific is currently under evaluation in current asset category among its peers.
CBSC Fundamentals
| Operating Margin | (14.86) % | |||
| Current Valuation | 20.95 M | |||
| Shares Outstanding | 120.03 M | |||
| Price To Book | 261.27 X | |||
| Price To Sales | 456.11 X | |||
| Revenue | 75.58 K | |||
| Gross Profit | 23.49 K | |||
| EBITDA | (4.8 M) | |||
| Net Income | (6.34 M) | |||
| Cash And Equivalents | 4.67 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (786.03 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 0.71 | |||
| Market Capitalization | 22.45 M | |||
| Total Asset | 653.97 K | |||
| Z Score | -23.1 | |||
| Net Asset | 653.97 K |
About CB Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CB Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CB Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CB Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CBSC Pink Sheet
CB Scientific financial ratios help investors to determine whether CBSC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CBSC with respect to the benefits of owning CB Scientific security.